In a recent article published in Cell, Kjaergaard et al. show that the skeletal muscle proteome and phosphoproteome are associated with whole-body insulin sensitivity, and identify selective insulin resistance (IR) signatures in individuals with and without type 2 diabetes (T2D).1 Their elegant work provides compelling evidence for more personalised therapeutic strategies to treat T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.